hypoestoxide

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 12/18/2015 - "Hypoestoxide (HE) has been demonstrated as a NF-κB modulator, thereby acting as a potential anti-inflammatory and anti-cancer drug. " 09/14/2007 - "Hypoestoxide inhibits tumor growth in the mouse CT26 colon tumor model."
2.	Parkinson Disease (Parkinson's Disease) 12/18/2015 - "Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's disease."
3.	Colonic Neoplasms (Colon Cancer) 09/14/2007 - "To evaluate the effect of the natural diterpenoid, hypoestoxide (HE) on the growth of established colon cancer in mice. "
4.	Neuroinflammatory Diseases 12/18/2015 - "Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's disease."